MedPath

山东汇泽生物制药有限公司

Ownership
-
Established
2022-03-24
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Gliclazide Modified Release Tablets

Product Name
格列齐特缓释片
Approval Number
国药准字H20254382
Approval Date
May 27, 2025
NMPA

Metformin Hydrochloride Sustained-release Tablets

Product Name
盐酸二甲双胍缓释片
Approval Number
国药准字H20244835
Approval Date
Sep 10, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.